Detalhe da pesquisa
1.
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.
N Engl J Med
; 385(12): 1091-1103, 2021 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161051
2.
A plain language summary of the TROPHY-U-01 study: sacituzumab govitecan use in people with locally advanced or metastatic urothelial cancer.
Future Oncol
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38682560
3.
Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(6): 597-610, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269841
4.
Response to RL-225Ac in prostate cancer: Effect of prior treatment with RL-177Lu: A systematic review of the literature.
Prostate
; 83(10): 901-911, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36960580
5.
Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic castration-resistant prostate cancer receiving prostate-specific membrane antigen targeted radionuclide therapy.
Prostate
; 83(14): 1351-1357, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37424145
6.
Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER).
BMC Cancer
; 23(1): 781, 2023 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37608258
7.
Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US.
Qual Life Res
; 32(11): 3209-3221, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37410340
8.
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study.
Lancet Oncol
; 23(2): 248-258, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35030333
9.
Pilot study of the diagnostic utility of 89 Zr-df-IAB2M and 68 Ga-PSMA-11 PET imaging and multiparametric MRI in localized prostate cancer.
Prostate
; 82(4): 483-492, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34985786
10.
Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma.
Br J Cancer
; 126(3): 430-439, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35046520
11.
Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma.
N Engl J Med
; 381(4): 338-348, 2019 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31340094
12.
Mechanisms of Ischemic Stroke in Patients with Cancer: A Prospective Study.
Ann Neurol
; 90(1): 159-169, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34029423
13.
Adherence to Guideline-Recommended Cancer Screening in Stroke Survivors: A Nationwide Analysis.
J Stroke Cerebrovasc Dis
; 31(3): 106297, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35032754
14.
Imaging expression of prostate-specific membrane antigen and response to PSMA-targeted ß-emitting radionuclide therapies in metastatic castration-resistant prostate cancer.
Prostate
; 81(5): 279-285, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33465252
15.
Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing.
Oncologist
; 26(11): e1971-e1981, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34286887
16.
Impact of Late Dosing on Testosterone Suppression with 2 Different Leuprolide Acetate Formulations: In Situ Gel and Microsphere. An Analysis of United States Clinical Data.
J Urol
; 205(2): 554-560, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33090917
17.
Arterial thromboembolic events preceding the diagnosis of cancer in older persons.
Blood
; 133(8): 781-789, 2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30578253
18.
A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticals.
Eur J Nucl Med Mol Imaging
; 48(8): 2642-2651, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33495926
19.
Prostate-Specific Membrane Antigen (PSMA)-Targeted Radionuclide Therapies for Prostate Cancer.
Curr Oncol Rep
; 23(5): 59, 2021 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33778927
20.
CD8+ T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens.
Mol Ther
; 28(5): 1238-1250, 2020 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32208168